You are here

shareholders

J&J outlines exchange offer for Kenvue shares

Medical Marketing and Media

Mon, 07/24/23 - 09:39 pm

Biogen shareholders vote in Susan Langer as director despite relationship with former board member

Fierce Pharma

Mon, 06/26/23 - 08:42 pm

Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider

Fierce Pharma

Fri, 06/9/23 - 11:49 am

Inflation Reduction Act

AstraZeneca wins federal class-action suit, judge dismisses shareholders' misleading claims

Endpoints

Tue, 09/13/22 - 07:57 pm

'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update

Fierce Pharma

Wed, 02/23/22 - 10:09 pm

Bristol Myers Squibb

FDA review of troubled drug could hobble AMAG in proxy fight with activist investor

Fierce Pharma

Thu, 09/26/19 - 07:43 pm

Amag Pharmaceuticals

5 Reasons Novartis Shareholders Aren't Shaken

Yahoo/Motley Fool

Mon, 08/12/19 - 10:32 am

‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp

Endpoints

Fri, 04/26/19 - 10:27 am

Novartis faces shareholder criticism over drug prices at AGM

Yahoo/Reuters

Thu, 02/28/19 - 09:53 am

Starboard gauges Bristol-Myers shareholder support for Celgene deal

Yahoo/Reuters

Sat, 02/16/19 - 03:39 pm

Bristol-Myers Squibb

Class Action Lawsuit Aims to Halt GSK Acquisition of Tesaro

BioSpace

Tue, 01/8/19 - 07:10 pm

Takeda could rack up $10B in selloffs after controversial Shire buyout: report

Fierce Pharma

Fri, 11/30/18 - 12:22 pm

Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains

Endpoints

Tue, 11/20/18 - 12:17 pm

Takeda investors mount last-minute effort to stymie Shire deal: FT

Fierce Pharma

Fri, 11/16/18 - 07:50 pm

Takeda CEO confident about Shire merger

Pharmaforum

Thu, 11/8/18 - 09:44 am

Christophe Weber

Intuitive Surgical to settle shareholders suit for $43m

Mass Device

Thu, 09/13/18 - 11:15 pm

Intuitive Surgical

Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor

Reuters

Thu, 06/28/18 - 07:15 pm

Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it

Fierce Pharma

Tue, 05/29/18 - 11:40 am

AstraZeneca pay report rejected by 35 percent of shareholders

Yahoo/Reuters

Fri, 05/18/18 - 09:30 pm

21% Of AbbVie Inc (ABBV) Shareholders Want To Know How Drug Pricing Is Integrated Into Incentive Programs

Value Walk

Sat, 05/5/18 - 11:15 am

Pages